/Edwards%20Lifesciences%20Corp%20Irvine%2C%20Ca%20campus-by%20Steve%20Cukrov%20via%20Shutterstock.jpg)
Edwards Lifesciences Corporation (EW), a global leader in patient-focused medical innovations, was founded in 1958 and is headquartered in Irvine, California. With a market cap of $42.2 billion, Edwards Lifesciences is a key player in the healthcare industry, specializing in cutting-edge technologies for structural heart disease and critical care monitoring.
Companies with a market value of $10 billion or more are classified as “large-cap stocks,” Edwards Lifesciences firmly belongs in this category. With a strong track record of financial performance and a commitment to advancing medical technology, Edwards excels in specialized healthcare sectors, including structural heart innovations and critical care solutions. Its innovative products and patient-focused approach drive significant impact across global healthcare markets.